BBB

BIO VITOS PHARMA AB

No trades
See on Supercharts
Market capitalization
‪6.13 M‬SEK
−0.2685SEK
‪−12.87 M‬SEK
‪3.00 M‬SEK
Beta (1Y)
3.61

About BIO VITOS PHARMA AB

CEO
Joen Averstad
Headquarters
Solna
Founded
2010
ISIN
SE0009320278
FIGI
BBG00G6RXWX5
Bio Vitos Pharma AB is a medical technology company. It engages in the business of producing and developing a concept for point-of-care detection of hemolysis in blood samples. The company was founded by Anders Mathias Karlsson and Per Hjalmar Olof Didrikson in 2010 and is headquartered in Solna, Sweden.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of BIOVIT is 0.1800 SEK — it has increased by 0.84% in the past 24 hours. Watch BIO VITOS PHARMA AB stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange BIO VITOS PHARMA AB stocks are traded under the ticker BIOVIT.
BIOVIT stock is 1.39% volatile and has beta coefficient of 3.61. Track BIO VITOS PHARMA AB stock price on the chart and check out the list of the most volatile stocks — is BIO VITOS PHARMA AB there?
Yes, you can track BIO VITOS PHARMA AB financials in yearly and quarterly reports right on TradingView.
BIOVIT stock has fallen by 2.70% compared to the previous week, the month change is a 20.35% fall, over the last year BIO VITOS PHARMA AB has showed a 20.00% decrease.
BIOVIT net income for the last quarter is ‪−5.08 M‬ SEK, while the quarter before that showed ‪−3.44 M‬ SEK of net income which accounts for −47.41% change. Track more BIO VITOS PHARMA AB financial stats to get the full picture.
Today BIO VITOS PHARMA AB has the market capitalization of ‪6.13 M‬, it has decreased by 5.31% over the last week.
No, BIOVIT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, BIOVIT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIO VITOS PHARMA AB stock right from TradingView charts — choose your broker and connect to your account.
BIOVIT reached its all-time high on Dec 22, 2023 with the price of 0.3390 SEK, and its all-time low was 0.1410 SEK and was reached on Jan 31, 2024. View more price dynamics on BIOVIT chart.
See other stocks reaching their highest and lowest prices.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BIO VITOS PHARMA AB EBITDA is ‪−3.50 M‬ SEK, and current EBITDA margin is −116.95%. See more stats in BIO VITOS PHARMA AB financial statements.